Personalizing
Cancer Treatment for Everyone

WEBINAR

Childhood Cancer
Precision in Pediatrics: Diagnosing and Curing Childhood Cancer

Caregivers, cancer patients, and loved ones, you can watch this webinar about childhood cancer by  Dr. Jason Freedman, Dr. Gerald Wertheim and Dr. Sarah Tasian.

If you missed the webinar, you can still watch the recording here.

 

Ask our doctors your questions about cancer
Panel of Doctors Answer Your Questions About Cancer

Caregivers, patients, and loved ones joined Dr. Belisario Arango and Dr. Arturo Loaiza-Bonilla on Monday, June 19, 12 pm EDT for this very informative and interactive question and answer panel format webinar. 

Our doctors answered participants questions submitted during the webinar and ones that have been sent to Massive Bio. 

Cancer Treatment Doctor
Bringing state-of-the-art precision cancer care Bringing state-of-the-art precision cancer care to rural communities

Bringing state-of-the-art precision cancer care was aired Tuesday, March 14 at 12:00 EDT. 

Dr. Belisario Arango covered the following topics:

Why there is a higher cancer prevalence in patients in rural areas?
What are the challenges delivering cancer care to patients? 
Where is the future of cancer care going?

VIEW ALL ARTICLES

PRESS RELEASES

Holiday Savings New Year 2018 for Cancer Patients
2018 New Year Holiday Savings

We are starting our New Year Holiday Savings early and ending it late!
 

Cancer Treatment Black Friday Deal
Cancer Treatment Black Friday Opportunity

Massive Bio is in the holiday spirit this year, so we are starting our Black Friday deal early and ending it late! Give thanks to those you love by giving them the gift of Massive Bio to find the best cancer treatment for your loved one or for yourself.

 

Feasibility Of Precision Oncology Virtual Tumor Boards To Optimize Direct Point-Of-Care Management And Clinical Trial Enrollment Of Advanced Cancer Patients
Feasibility Of Precision Oncology Virtual Tumor Boards To Optimize Direct Point-Of-Care Management And Clinical Trial Enrollment Of Advanced Cancer Patients

Precision oncology encompasses the implementation of high level of evidence disease-specific and biomarker-driven diagnostic and treatment recommendations for optimized cancer care.

VIEW ALL ARTICLES

IN THE NEWS

FDA-approved drug to combat alcoholism could kill cancer by 'freezing' tumor growth
FDA-approved drug to combat alcoholism could kill cancer by 'freezing' tumor growth

An old drug prescribed to help people stop drinking alcohol may be an effective cancer-killer, according to new study. 

 

Caterina Bellandi dancing around her first taxi, now a monument in the Garden of Horticulture in Florence.
'Taxi Therapy' in Italy for Young Cancer Patients

The black-and-white checkered floor of the taxi looks a bit like home flooring. The seats are yellow, purple and orange leather, while the pea-green interiors are plastered with daisy stickers. When riding in the cab, passengers can play with plastic swords and a megaphone, or make soap bubbles.

About 140 million women use some type of hormonal contraception, including about 16 million in the United States.
Birth control pills raise breast cancer risk, research shows

About 140 million women use some type of hormonal contraception, including about 16 million in the United States. But a large Danish study published Wednesday suggests that, like older pills, they still modestly raise the risk of breast cancer, especially with long-term use.

 

Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage
Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

Researchers at the University of Cincinnati (UC) College of Medicine have shown that a new targeted treatment could benefit patients with certain pancreatic tumors by preventing spread of the cancer and protecting their heart from damage—a direct result of the tumor. Higher levels of serotonin among other tumor secretions can cause injury to the valves of the heart over time, leading to cardiac impairment—a condition referred to as cardiac carcinoid disease—in these patients. 

 

VIEW ALL ARTICLES

PUBLISHED RESEARCH

Clinical outcome of patients with metastatic renal cell carcinoma who interrupted VEGFR-TKI after achieving stable disease or better response.
Clinical outcome of patients with metastatic renal cell carcinoma who interrupted VEGFR-TKI after achieving stable disease or better response.

The purpose of the this study is to evaluate the clinical outcome of VEGFR-TKIs interruption in patients with metastatic renal cell carcinoma (mRCC) after achieving stable disease (SD) or better response.

Tumors continuously evolve to maintain growth; secondary mutations facilitate this process, resulting in high tumor heterogeneity.
Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer

Tumors continuously evolve to maintain growth; secondary mutations facilitate this process, resulting in high tumor heterogeneity. In this study, we compared mutations in paired primary and metastatic colorectal cancer tumor samples to determine whether tumor heterogeneity can predict tumor metastasis.

Docetaxel-based chemotherapy led to significant improvement in progression-free (PFS) and overall survival for patients
Overall Survival Rate Increased in Gastric Cancer

Docetaxel-based chemotherapy led to significant improvement in progression-free (PFS) and overall survival for patients with resectable gastric or gastroesophageal juncture (GEJ) cancer, according to a study reported at the European Society for Medical Oncology conference in Madrid.

Swelling from Lymphedema Falls after Liposuction
Liposuction Reduces Swelling and Pain Associated with Lymphedema

Liposuction for primary or secondary lymphedema led to substantial reductions in limb swelling and associated pain, according to a case report in the New England Journal of Medicine.

VIEW ALL ARTICLES

NEWSLETTER

Massive Bio is Your Advisor for Precision Cancer Care Options
Massive Bio Fights for You

Cancer patients, caregivers and oncologists - we would like to introduce ourselves as your next step toward fighting cancer. Massive Bio, Inc., headquartered in New York, is an innovative digital health company that brings the latest and greatest in cancer care to the point of need.

VIEW ALL ARTICLES
Stay in Touch with Us
To speak with a dedicated cancer care specialist, contact us by one of the options listed below:
PLEASE FILL OUT FORM BELOW

X
Talk to Cancer Care Experts:
+1 (844) 627-7246
Top